What is the appropriate work‑up for a patient with elevated IgG, normal immunofixation, and a free kappa/lambda ratio of 1.44?

Work-Up for Elevated IgG with Normal Immunofixation and κ/λ Ratio of 1.44

In a patient with elevated IgG, normal immunofixation, and a free light chain ratio of 1.44 (within the normal range of 0.26–1.65), the elevation most likely reflects polyclonal hypergammaglobulinemia rather than a monoclonal process, and the work-up should focus on assessing renal function and excluding secondary causes of B-cell activation. 1

Initial Assessment

1. Evaluate Renal Function

• Calculate estimated glomerular filtration rate (eGFR) immediately, as even modest renal impairment (eGFR <60 mL/min/1.73 m²) causes proportional elevation of both kappa and lambda free light chains while preserving a normal ratio. 1
• Free light chains are cleared renally; any reduction in glomerular filtration leads to proportional increases in both chains without disturbing the κ/λ ratio. 1
• In severe chronic kidney disease (CKD stage 5), the "normal" ratio range shifts upward to 0.34–3.10, making your patient's ratio of 1.44 even more reassuring. 1

2. Complete the Monoclonal Protein Work-Up

Despite the normal κ/λ ratio, complete the following tests to definitively exclude a monoclonal process: 1

• Serum protein electrophoresis (SPEP): Quantitative, inexpensive first-line screening that may detect an M-spike missed by other methods. 1
• 24-hour urine protein electrophoresis with immunofixation: Most sensitive for detecting urinary light chains (Bence Jones protein), as approximately 50% of patients with monoclonal gammopathy detected by immunofixation can have normal κ/λ ratios. 1, 2
• Repeat serum immunofixation if not already performed recently: Confirms absence of monoclonal protein, though you report this as normal. 1

Critical pitfall: Research shows that 44.6–50.7% of patients with IgG and IgA monoclonal proteins detected by immunofixation have normal κ/λ ratios, particularly when M-components are small. 2 This underscores why urine studies remain essential even when the serum ratio appears normal.

3. Assess for Polyclonal Causes

If no monoclonal protein is detected on complete work-up, investigate causes of polyclonal hypergammaglobulinemia: 1

• Chronic inflammatory conditions: Rheumatoid arthritis, systemic lupus erythematosus, Sjögren syndrome
• Chronic infections: HIV, hepatitis C, chronic bacterial infections
• Autoimmune liver disease: Primary biliary cholangitis, autoimmune hepatitis
• Lymphoproliferative disorders: Non-clonal B-cell activation

Risk Stratification

Your patient does NOT meet criteria for intermediate or high-risk MGUS based on current findings: 3

• Low-risk MGUS is defined as: serum M-protein <15 g/L, IgG type, and normal FLC ratio. 3
• Since immunofixation is normal (no detectable M-protein) and the κ/λ ratio is normal (1.44), this patient does not have MGUS at all—they have polyclonal elevation. 3, 1

Management Algorithm

If Renal Function is Normal and No Monoclonal Protein Detected:

• No bone marrow biopsy is indicated in the absence of unexplained anemia, renal insufficiency, hypercalcemia, or bone lesions. 3
• No skeletal radiography is needed if clinical evaluation and laboratory parameters (complete blood count, serum calcium, creatinine) are normal. 3
• Repeat SPEP in 3–6 months to ensure stability and exclude evolving monoclonal process. 3
• If stable, follow every 2–3 years or when symptoms arise. 3

If Renal Impairment is Present:

• Recognize that the elevated IgG and any FLC elevation are likely secondary to reduced clearance. 1
• Consider the N Latex FLC assay if repeat testing is needed, as it is less influenced by renal impairment than the FreeLite assay. 1
• Monitor renal function and treat underlying kidney disease.

Key Caveats

• Assay-specific limitations: Two major FLC assays (FreeLite and N Latex) yield mathematically non-convertible results; always use the same assay for longitudinal monitoring. 1, 4
• Lambda chain underdetection: Lambda-dominant monoclonal processes are detected less frequently by κ/λ ratio abnormalities; approximately 25% of lambda light chain lesions may show normal ratios despite detectable free lambda chains in urine. 5
• Recent drift in kappa FLC measurements: Some laboratories have reported upward drift in kappa FLC quantitation, potentially reducing specificity for monoclonal kappa in the 1.65–3.0 ratio range. 6

When to Refer to Hematology

Refer if any of the following develop: 1

• End-organ damage: unexplained anemia, hypercalcemia, bone lesions, or renal dysfunction not explained by other causes
• Detection of a monoclonal protein on immunofixation despite normal κ/λ ratio
• Clinical suspicion for monoclonal gammopathy of renal significance (MGRS) in unexplained kidney disease

In your patient's case, with normal immunofixation, normal κ/λ ratio, and elevated IgG alone, hematology referral is not indicated unless the above red flags emerge. 3, 1